About YPrime

The Basics on YPrime

We are a Passionate, Engaged and Flexible Organization… Who Provide our Clients the Expertise and Support to Meet their Needs.

At YPrime, we know systems and clinical research– and are committed to forward-thinking solutions. From our origins as eclinical technology consultants for the biopharma industry, this is how we developed powerful applications to advance critical data functions for clinical research. Understanding and knowledge come from experience. YPrime offers more than a decade of focused work with clinical systems to expedite and improve the quality of patient management, clinical supplies, drug accountability and clinical data. Our mission is simple: To support our clients in the timely and accurate completion of innovative research that gets them to the next stage in their drug development projects.

How do we achieve this mission?

It starts with a track record of thinking differently, which means product innovation and problem solving. We provide choice and execution flexibility through customizable and configurable solutions. Our teams support complex studies across a wide range of indications from Phase I-IV. It is also about dedication – dedication to innovation, discovering how to make things better and finding simpler paths to the next big milestone. Most important, it is about our values – the quality of our delivery and engagement with our clients comes from a company-wide focus on integrity, accountability and teamwork. Finally, we’ve earned a reputation for providing a straightforward and uncomplicated customer experience. Because clinical research is complex enough.

Leadership Team

Shawn Blackburn

CEO

linked-in

As CEO, Shawn Blackburn provides strategic leadership and direction for YPrime. With a background in systems architecture and information management, Shawn has a built a reputation for helping companies discover insights about future opportunities by bringing together siloed information in meaningful context to support strategic decision making.

Since co-founding YPrime in 2006, Shawn has lead the company growth from a two-person consulting firm to a global organization that focuses on evolving technologies to help accelerate development timelines, simplify process complexity, and improve data quality across the clinical development continuum.

Prior to YPrime, Shawn had a long career as a technology consultant for Cephalon and Parexel. While at Cephalon, he was instrumental in the company’s development of applications to improve clinical trial workflow and provide deeper visibility into clinical trial performance.

Jaime Cook

Executive Vice President

linked-in

Jaime Cook is Executive Vice President of Consulting. In this role, he leads YPrime’s efforts to help biopharmaceutical companies gain full visibility into their clinical data for deeper insights and faster decision-making through information integration, management and system support. Jaime brings extensive knowledge of clinical systems, cloud-based technology and programming languages. Since co-founding YPrime in 2006, Jaime has held a number of leadership roles, where he shaped the company’s business consulting and customer care functions.

Earlier, Jaime worked as a technical consultant and systems analyst for Cephalon, Merck and Perceptive Informatics. Throughout his earlier career, Jaime led development efforts for enterprise and purpose-built applications that integrated and displayed clinical data across organizations. The impact of these implementations resulted in faster deployments, detection of trends and decision-making support for a range of investigational products.

He began his career as a systems analyst at Dupont Pharmaceuticals (now part of Bristol-Myers Squibb). Jaime earned a bachelor of science degree in computer science from Towson State University.

Mark Maietta

Chief Commercial Officer

linked-in

Mark Maietta leads the company’s commercial strategy as Chief Commercial Officer. With oversight of sales, marketing and business development functions, he is responsible for ensuring the company’s commercial objectives and service delivery align and evolve with customer needs.

Mark brings more than 20 years of focused leadership experience within life sciences and technology sectors. Most recently, Mark served as Chief Commercial Officer for Clariness, a provider of digital patient recruitment and engagement solutions. There, he built and led global commercial infrastructure to drive revenue and position the company as a global leader. Prior to Clariness, Mark was Chief Business Officer at AdviseClinical, a clinical strategic advisory and staffing organization.

During his tenure as Senior Vice President of Business Development and Marketing for CRF Health, Mark re-designed business development and marketing practices to increase productivity and improve sales results. Early career positions with OPTUMInsight (now part of United Health Group), Pfizer and Novartis Pharmaceuticals included sales management and field sales positions.

Mark earned a master of business administration degree from Binghamton University. He received a bachelor of science degree in marketing from Ithaca College.

Board of Directors

matt-rice-bw

Matt Rice

Chairman of the Board

Matt Rice is a Partner of Ballast Point Ventures. He leads the company’s healthcare practice and currently serves on the board of directors at Molecular MD, TissueTech, MeYou Health, Theragen and Inconixx.  Prior to joining Ballast Point Ventures in 2004, Mr. Rice began his career in the healthcare investment banking group of Raymond James Financial, where he focused on specialty pharmaceutical, drug distribution and contract research organization sectors. Mr. Rice also worked in the strategic alliances group at the Novartis Institutes for BioMedical Research prior to rejoining Ballast Point Ventures as a vice president in 2008.

Mr. Rice received a master of business administration degree from Harvard University and earned a bachelor of science degree in commerce from the University of Virginia.

Shawn-circle2

Shawn Blackburn

CEO, Board of Directors

As CEO, Shawn Blackburn provides strategic leadership and direction for YPrime. With a background in systems architecture and information management, Shawn has a built a reputation for helping companies discover insights about future opportunities by bringing together siloed information in meaningful context to support strategic decision making.

Since co-founding YPrime in 2006, Shawn has lead the company growth from a two-person consulting firm to a global organization that focuses on evolving technologies to help accelerate development timelines, simplify process complexity, and improve data quality across the clinical development continuum.

Prior to YPrime, Shawn had a long career as a technology consultant for Cephalon and Parexel. While at Cephalon, he was instrumental in the company’s development of applications to improve clinical trial workflow and provide deeper visibility into clinical trial performance.

Jaime-circle2

Jaime Cook

VP Customer Care, Board of Directors

Jaime Cook is Executive Vice President of Consulting. In this role, he leads YPrime’s efforts to help biopharmaceutical companies gain full visibility into their clinical data for deeper insights and faster decision-making through information integration, management and system support. Jaime brings extensive knowledge of clinical systems, cloud-based technology and programming languages. Since co-founding YPrime in 2006, Jaime has held a number of leadership roles, where he shaped the company’s business consulting and customer care functions.

Earlier, Jaime worked as a technical consultant and systems analyst for Cephalon, Merck and Perceptive Informatics. Throughout his earlier career, Jaime led development efforts for enterprise and purpose-built applications that integrated and displayed clinical data across organizations. The impact of these implementations resulted in faster deployments, detection of trends and decision-making support for a range of investigational products.

He began his career as a systems analyst at Dupont Pharmaceuticals (now part of Bristol-Myers Squibb). Jaime earned a bachelor of science degree in computer science from Towson State University.

james-c-walker

Dr. James C. Walker

Board of Directors

Over the course of a 23 year career, Jim Walker has served as CEO and Chairman of a venture-backed company for 13 of those years. Jim founded and was CEO and Chairman of Octagon Research Solutions, Inc. (Octagon), a global pharmaceutical services and software company. Octagon was acquired by Accenture (NYSE: ACN) in September, 2012. Prior to founding Octagon, Jim worked as a Regulatory Affairs professional at both Johnson & Johnson and Schering-Plough. Jim is currently the Chairman and CEO of Zoomi, Inc.

Jim is a graduate of Villanova University earning a bachelor of science degree in science comprehensive. Jim also earned an master of science degree in environmental science from Rutgers University and a master in business administration degree from Duke University and his Doctorate degree from the University of Pennsylvania. His dissertation was an exploratory study on adaptability in the workplace.

Jim has won the following awards: Ernst & Young Entrepreneur of the Year, Recipient of the “Stevie Award” for Most Innovative Company at the American Business Awards, Enterprise Awards Technology CEO of the Year and Enterprise Awards Company of the Year.

Jim served on the Board of Directors for the Cadient Group, acquired by Cognizant (Nasdaq: CTSH) in October, 2014. Jim is also the Chairman of TrialScope, Inc. and Zoomi, Inc. He also serves on the Advisory board of EmeraldStage2 ventures.

Travis Milks

Travis Milks

Board of Directors

Travis Milks is a Partner of Stonehenge Growth Equity Partners, a growth equity investment firm focused on high growth, technology-enabled businesses. Mr. Milks currently maintains board responsibilities at Stonehenge portfolio companies YPrime, Thrive, Choice Legal, and Proficient Auto Transport (observer). Mr. Milks previously held board observation responsibilities for VectorLearning, Inc. (sold to a financial sponsor) and Dixie-Southern (sold to a strategic acquirer).

Prior to joining Stonehenge, Mr. Milks worked in the Investment Banking Group at Morgan Keegan & Company. While at Morgan Keegan, he assisted clients from various segments of the technology marketplace including enterprise software, specialty semiconductors and security technologies. He also worked as a Summer Business Development Manager in the Online Services Division of Microsoft Corporation.

Mr. Milks earned a bachelor of science degree in finance, with honors, from the University of Tampa and a master of business administration degree from the Harvard Business School.

Locations

Raleigh, NC
3301 Benson Dr, Suite 300
Raleigh, NC 27609

Malvern, PA
263 Great Valley Parkway
Malvern, PA 19355

Contact Us






Locations in:
USA, UK, Macedonia, Australia, China